Keyphrases
Colorectal Peritoneal Metastases
80%
Peritoneal Metastasis
41%
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
40%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
40%
Oxaliplatin
26%
Confidence Interval
24%
Netherlands
22%
Odds Ratio
20%
Evidence-based Practice
20%
Chemotherapy Alone
20%
Chemotherapy
20%
Randomized Clinical Trial
20%
Population-based Study
20%
Systemic Pharmacokinetics
20%
Cytoreductive Surgery
20%
Intraperitoneal Administration
20%
Preoperative Systemic Therapy
20%
Combined Modality Therapy
20%
Equal Access
20%
National Cohort Study
20%
Curative Surgery
13%
After Surgery
13%
Before Surgery
13%
Hospital of Diagnosis
8%
Neoadjuvant
8%
Neoadjuvant Therapy
8%
Leucovorin
7%
Endometrial Cancer
7%
Colorectal Cancer
6%
Biologically Active
6%
INIS
metastases
100%
patients
82%
chemotherapy
76%
surgery
55%
populations
41%
aerosols
24%
netherlands
22%
cancer
22%
electrostatics
20%
origin
20%
therapy
20%
clinical trials
20%
administration
20%
leucovorin
7%
hospitals
6%
fluorouracils
6%
ovaries
5%
comparative evaluations
5%
probability
5%
risks
5%
hazards
5%
Medicine and Dentistry
Peritoneum Metastasis
80%
Cytoreductive Surgery
40%
Hyperthermic Intraperitoneal Chemotherapy
40%
Odds Ratio
21%
Randomized Clinical Trial
20%
Systemic Therapy
20%
Chemotherapy
20%
Neoadjuvant Therapy
8%
Overall Survival
7%
Cervical Cancer
7%
Ovarian Cancer
7%
Uterine Cancer
7%
Folinic Acid
6%
Capecitabine
6%
Fluorouracil
6%
Oxaliplatin
6%
Arm
6%
Adverse Event
5%
Disease
5%
Quality of Life
5%
Awareness
5%
Hazard Ratio
5%
Colorectal Carcinoma
5%
